权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Renin angiotensin system and connexin43

肾素血管紧张素系统和连接蛋白43

基本信息

批准号：
8597392
负责人：
SAMUEL C DUDLEY
金额：
--
依托单位：
JESSE BROWN VA MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
2010
资助国家：
美国
起止时间：
2010-10-01 至 2014-09-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8597392
关键词：
Address Admission activity American Amino Acids Angiotensin I Angiotensin II Angiotensin Receptor Angiotensin-Converting Enzyme Inhibitors Arrhythmia Ascorbic Acid Atrial Fibrillation Biological Availability Biological Markers Blood Pressure Canis familiaris Cardiac Cardiovascular system Cessation of life Cleaved cell Clinical Connexin 43 Connexins Coronary Artery Bypass Coupling Data Defect Electric Stimulation Enzyme Inhibition Event Family suidae Generations Glutathione Disulfide Healthcare Heart Heart Atrium Heart Diseases Heart failure Hospitals Human Hydrogen Peroxide Hydroxyl Radical Hypertension Incidence Intervention Ion Channel Knockout Mice Lead Left Link Lipid Peroxidation Measures Mediating Mediator of activation protein Messenger RNA Modeling Mus NADPH Oxidase Nitric Oxide Nodal Oxidation-Reduction Oxidative Stress Pathology Patients Peptides Peptidyl-Dipeptidase A Performance Pericardial effusion Peroxonitrite Phenotype Postoperative Period Predisposition Procedures Production Proteins Pulmonary Edema Receptor, Angiotensin, Type 1 Regulation Relapse Renin-Angiotensin System Risk SRC gene Shapes Signal Pathway Signal Transduction Signaling Molecule Solid Sudden Death Superoxides Surface System Testing Tissues Up-Regulation Ventricular Ventricular Arrhythmia Ventricular Tachycardia Veterans abstracting activating transcription factor ascorbate base human NOS3 protein improved inhibitor/antagonist insight mortality mouse model nitration novel novel diagnostics novel therapeutic intervention overexpression oxidant stress oxidation oxidized lipid prevent prospective public health relevance therapy development tool voltage

项目摘要

DESCRIPTION (provided by applicant): Project abstract. Activation of the renin-angiotensin system (RAS) system is associated with increased cardiovascular death. A critical component of this system is angiotensin converting enzyme (ACE), which cleaves the decapeptide angiotensin I, producing the eight amino acid peptide angiotensin II (AngII), a central signaling molecule of the RAS system. In humans, increased AngII levels are associated with an increased ventricular arrhythmic risk, and use of ACE inhibitors reduces that risk. To investigate RAS induced arrhythmias, we developed a cardiac-restricted ACE overexpression mouse that shows an increased risk of sudden death in the absence of heart failure or structural heart disease. In this application, we show that AngII- mediated oxidative stress activates the transcription factor NFkB via H2O2 production, c-Src is transcriptionally upregulated in our model, and ACE mice have reduced Cx43 protein in the absence of changes in mRNA abundance. Therefore, we will test to what extent AngII leads to oxidative stress which in-turn alters Cx43, contributing to the ACE 8/8 arrhythmic phenotype. This will be tested in 4 aims. In each aim, we will establish to what extent measures of oxidative stress, NFB, c-Src, Cx43, and arrhythmic risk are altered by the disruptions in the proposed signaling cascade. The aims are constructed to test a specific, plausible signaling cascade and simultaneously establish the order of the intermediates in the cascade. Specific aim 1: To establish to what extent AngII-mediated signaling is responsible for the Cx43 regulation in our ACE overexpression model. Specific aim 2: To establish to what extent NADPH oxidase activation is responsible for the Cx43 regulation in our ACE overexpression model. Specific aim 3: To establish to what extent increased NFkB activation is responsible for the Cx43 regulation in our ACE overexpression model. Specific aim 4: To establish to what extent increased c-Src upregulation is responsible for the Cx43 regulation in our ACE overexpression model. PUBLIC HEALTH RELEVANCE: Potential Impact to Veterans Health Care. Heart failure is one of the most common causes of hospital admission and death in veterans and all Americans. Inhibiting angiotensin II signaling in heart failure has improved mortality by reducing sudden and non-sudden death. This project will address an important clinical problem of how do angiotensin II inhibitors reduce sudden death risk. This is likely to lead to new insights into how sudden death risk is incurred in conditions of reduced cardiac function. Specifically, this application will give a more complete picture of the pro-arrhythmic effects of AngII on heart, which could lead to new diagnostic and therapeutic interventions.

描述（由申请人提供）：